GKOS (Glaukos) מכפיל EV/Sales

Glaukos Corp (GKOS) - לוגו תאגידי

Glaukos Corporation (GKOS) possesses significant pricing power due to its unique patented implants. The business valuation relative to revenue reflects current price action, where the value of 20077.44 serves as the current metric. The integration of drug-eluting stents is transforming glaucoma therapy standards, while high margins are sustained by FDA approval and broad insurance coverage for minimally invasive surgeries.

GKOS יחס שווי פעילות להכנסות Glaukos (23.11.2025 - 20.11.2026)

פילוחי מדדים פיננסיים ומדדי שוק עבור Glaukos Corp. (GKOS)

- ציטוטים נוכחיים ותחזית שווי ממוצעת:
הערכת שווי פונדמנטלית של החברה:Glaukos Corporation
מוצר מקורי של Glaukos Corp

To identify fundamental benchmarks in the financial statements of Glaukos Corporation (GKOS), analyzing the enterprise value is critical. This indicator compares market capitalization and net debt against annual revenue, while the current enterprise value-to-revenue ratio confirms a premium for the company's unique patented implants and its significant pricing power within the ophthalmology market.